Delisting riskPopularity #4,664
Cardio Diagnostics (CDIO)
Develops genetic-epigenetic blood tests and clinical intelligence for coronary heart disease.
$1.89
vs last close−0.03 (−1.56%)
Something off on this page? Send us feedback.
Next report
Nov 6, 26
estimated · in 44 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.06−$0.97−$0.97−$0.98−$0.80−$0.63−$0.51Pending
Estimate−$0.16−$1.80−$1.80−$1.80−$1.80———
Surprise+62.5%+46.1%+46.1%+45.6%+55.6%———
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$25.0K$940$7.5K$2.9K$3.6K$2.7K$5.4KPending
Estimate$25.0K$50.0K$75.0K$150.0K$250.0K———
Surprise0.0%−98.1%−90.0%−98.1%−98.6%———
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2030 | −$1.80 | — | — |
| Dec 2029 | −$1.80 | — | — |
| Sep 2029 | −$1.80 | — | — |
| Jun 2029 | −$1.80 | — | — |
| Mar 2029 | −$1.80 | — | — |
| Dec 2028 | −$1.80 | — | — |
| Sep 2028 | −$1.80 | — | — |
| Jun 2028 | −$2.70 | — | — |
| Mar 2028 | −$4.05 | — | — |
| Dec 2027 | −$8.25 | — | — |
| Sep 2027 | −$11.70 | — | — |
| Jun 2027 | −$4.35 | — | — |
| Mar 2027 | −$2.70 | — | — |
| Dec 2026 | −$19.80 | — | — |
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$0.51 | — |
| May 2026 | — | −$0.63 | — |
| Mar 2026 | −$1.80 | −$0.80 | +55.6% |
| Nov 2025 | −$1.80 | −$0.98 | +45.6% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Jun 2021 | |||
| Mar 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2030 | −$1.80 | — | — | $250.0K | — | — | — |
| Dec 2029 | −$1.80 | — | — | $150.0K | — | — | — |
| Sep 2029 | −$1.80 | — | — | $75.0K | — | — | — |
| Jun 2029 | −$1.80 | — | — | $50.0K | — | — | — |
| Mar 2029 | −$1.80 | — | — | $25.0K | — | — | — |
| Dec 2028 | −$1.80 | — | — | $7.0K | — | — | — |
| Sep 2028 | −$1.80 | — | — | $8.0K | — | — | — |
| Jun 2028 | −$2.70 | — | — | $50.0K | — | — | — |
| Mar 2028 | −$4.05 | — | — | $250.0K | — | — | — |
| Dec 2027 | −$8.25 | — | — | $10.0K | — | — | — |
| Sep 2027 | −$11.70 | — | — | $7.9K | — | — | — |
| Jun 2027 | −$4.35 | — | — | $7.3K | — | — | — |
| Mar 2027 | −$2.70 | — | — | $400.0K | — | — | — |
| Dec 2026 | −$19.80 | — | — | $100.0K | — | — | — |
| Nov 6, 2026 | — | — | — | — | — | — | — |
| Aug 7, 2026 | — | −$0.51 | — | — | $5.4K | — | +7.8% |
| May 15, 2026 | — | −$0.63 | — | — | $2.7K | — | −10.3% |
| Mar 13, 2026 | −$1.80 | −$0.80 | +55.6% | $250.0K | $3.6K | −98.6% | −13.9% |
| Nov 12, 2025 | −$1.80 | −$0.98 | +45.6% | $150.0K | $2.9K | −98.1% | −9.1% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Apr 1, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 12, 2024 | |||||||
| Jul 1, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Feb 12, 2024 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 |